Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
6 p.
item.page.accessRights
item.page.other
item.page.references
Abstract
Background: The tyrosine kinase inhibitor pazopanib is used for treatment of sarcoma. Recent studies have suggested that the use of pazopanib may lead to the development of pneumothorax, an unexpected...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
BMC Cancer (2018) 18:937
Keywords
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026